CELL INTELLIGENCE · 肿瘤细胞治疗研究

老年宿主，年轻模型：重新思考衰老过程中的癌症免疫逃逸

Old Hosts, Young Models: Rethinking Cancer Immune Evasion in Aging.

下一代脐血扩增：以生物工程微环境弥合细胞剂量缺口与临床突破

"Next-Generation Cord Blood Expansion: Bridging the Cell Dose Gap with Bioengineered Niches and Clinical Breakthroughs".

局部晚期直肠癌输注吉西他滨新辅助放化疗：免疫细胞浸润分析与更新生存

Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival.

从激素免疫调节到胶质母细胞瘤治疗：Ouabain 的新兴作用

From hormonal immunomodulation to glioblastoma therapy: the emerging role of Ouabain.

异基因造血干细胞移植后儿童白血病患者的过继性细胞疗法

Adoptive Cellular Therapies in Pediatric Leukemia Patients After Allogeneic-Hematopoietic Stem Cell Transplants.

挖掘新兴骨肉瘤治疗中免疫学方法的复杂性：一项结合最新临床试验的综合叙述性综述

Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clin

儿童成熟 T/NK 细胞淋巴瘤的异基因造血干细胞移植

Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children.

杀伤细胞免疫球蛋白样受体及其同源 HLA I 类配体与伊朗患者急性髓系白血病易感性的关联

Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Irania

通过干细胞来源 NK 细胞的肿瘤免疫治疗

Cancer immunotherapy via stem cell-derived NK cells.

TMIGD2 作为胶质瘤患者的潜在治疗靶点

TMIGD2 as a potential therapeutic target in glioma patients.

我们的结果突显了 TMIGD2 在胶质瘤进展中的密切关联，并显示其作为免疫治疗刺激性靶点的有前景的治疗潜力。